New cell injection aims to rescue cancer Patients' platelets

NCT ID NCT07110090

Recruiting now Disease control Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Source: ClinicalTrials.gov ↗

Summary

This is an early safety study testing a single injection of specialized cells derived from umbilical cord blood. The goal is to see if the injection is safe and can help raise platelet counts in cancer patients whose platelets have dropped due to chemotherapy or other cancer treatments. The study will test three different dose levels in a small group of patients and monitor them closely for side effects for 28 days.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cancer Hospital Chinese Academy of Medical Sciences 17 Panjiayuan Nanli, Chaoyang District
RECRUITING

Beijing, Beijing Municipality, 100021, China

Conditions

Explore the condition pages connected to this study.

CANCER THROMBOCYTOPENIA